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Early physical rehabilitation may improve physical quality of life domains in
patients admitted to ICU with sepsis syndromesSynopsisSummary of: Kayambu G, Boots R, Paratz J. Early physical
rehabilitation in intensive care patients with sepsis syndromes: a
pilot randomised controlled trial. Intensive Care Med. 2015;
Published online [4_TD$DIFF]8 April 2015.
Question: Does early physical rehabilitation improve physical
function in intensive care patients with sepsis syndromes? Design:
Randomised controlled trial with concealed allocation and blinding
of participants and outcome assessors. Setting: A quaternary
hospital general intensive care unit (Royal Brisbane and Women’s
Hospital, Australia). Participants: Inclusion criteria were: aged 
18 years, mechanically ventilated  48 hours and diagnosed with
sepsis, severe sepsis or septic shock. Exclusion criteria were: the
presence of head injury, burns, spinal injury, multiple fractured
lower limbs, unresponsive tomaximal treatment or expected to die
 48 hours. Randomisation of the 50 participants allocated 26 to an
intervention group and 24 to a standard care group. Interventions:
The intervention group commenced individualised, targeted physi-
cal rehabilitationwithin 48 hours of sepsis diagnosis. Rehabilitation
comprised electricalmuscle stimulation, active and passive range of
motion, sitting out of bed and other mobilisation techniques, as
appropriate, for 30 minutes, one to two times daily until discharge
from ICU. The standard care group received physical therapy
strategies provided by the ICU physiotherapist.Outcomemeasures:
The primary outcomes were: physical function, measured using the
Acute Care Index of Function at discharge from ICU; and quality of
life, measured using the Short Form-36 (SF-36) [5_TD$DIFF]6 months following1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B.V. Alhospital discharge. Secondary outcome measures included: the
Physical Function ICU Test; muscle strength measured using the
Medical Research Council muscle score; psychological outcome
measured using the anxiety subscale of the Hospital Anxiety and
Depression Scale; pro-inﬂammatory and anti-inﬂammatory activity
measured using cytokines.Results: Fifty participants completed the
study. At discharge from ICU, there was no between-group
difference in the Acute Care Index of Function (mean difference
[6_TD$DIFF] points, 95% CI –12 to 24[1_TD$DIFF]). Sixmonths following hospital discharge,
compared with the standard care group, those in the intervention
group reported better physical function ([7_TD$DIFF]22, 95% CI [8_TD$DIFF]1 to [9_TD$DIFF]43 points)
and physical role ([10_TD$DIFF]44, 95% CI [11_TD$DIFF] 5 to [12_TD$DIFF]74 points) domains on the SF-36.
Over the ICU stay, there was a greater change in interleukin-10 (in
favour of the intervention group) and tumour necrosis factor-a (in
favour of the standard care group). There were no other between-
group differences. Conclusion: Early physical rehabilitation im-
proved physical quality of life domains in patients admitted to ICU
with sepsis syndromes.
[95% CIs calculated by the CAP Editor.]
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http://dx.doi.org/10.1016/j.jphys.2015.05.002CommentarySurvivors of sepsis syndromes commonly have long-lasting
functional impairments,1 with few proven treatments. Attempting
to improve these outcomes, Kayambu and colleagues performed a
pilot randomised controlled trial of physical rehabilitation early in
the course of sepsis. The authors concluded that their intervention
‘improve(s) self-reported physical function and induce(s) systemic
anti-inﬂammatory effects.’
[1_TD$DIFF]While these authors are to be lauded for conducting an
important trial, it is difﬁcult to agree that this study supports [2_TD$DIFF]their
conclusions.[3_TD$DIFF] There are several reasons for this assertion[4_TD$DIFF].
There is confusion about which of the many outcomes is
‘primary’. The ﬁrst primary outcomewas ameasure of function (the
Acute Care Index of Function) assessed at discharge from ICU. The
second ‘primary’ outcome was the SF-36 by telephone at 6 months
following hospital discharge. Among many secondary outcomes,
three cytokines were measured at multiple times. With many
outcomes assessed, the chances of false-positive ﬁndings increase
signiﬁcantly.
The primary outcome was negative – the Acute Care Index of
Function was equal among groups at discharge from ICU. The
intervention group had high 6-month mortality (46% compared
with 17% among controls). The SF-36 was only assessed for
11 subjects in the intervention group, compared with 19 controls.
This introduced two additional threats (bias of differential follow-
up and lack of statistical stability); therefore, we should not
conclude that the intervention improved quality of life.Also, the multiple cytokine assessments and lack of an a priori
analysis plan reduces conﬁdence in a causal relationship between
the intervention and either decreasing inﬂammation (interleukin-
6) or increasing anti-inﬂammation (interleukin-10). Neither
association was ‘signiﬁcant’ after correction for multiple compar-
isons. The ﬁnding of a greater decline in TNF-alpha in the control
group further confuses the interpretation.
There is important work yet to be done to prove and achieve
beneﬁt from early rehabilitation in critically ill patients, with few
RCTs demonstrating efﬁcacy to date.2,3 Unfortunately, this new
study does not offer the level of evidence needed to move the
needle and change current clinical practice[5_TD$DIFF].
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